Saturday 17 October 2026
Export GCTK’s income statement to Excel — free account
GlucoTrack, Inc.
GCTK Healthcare Medical Instruments & Supplies
In the quarter to June 2026, EPS grew 92.1%, free cash flow grew 3.42% and total debt rose 777.8%, each against the same quarter a year earlier.
0.73
0.10
−12.05%
Follow GCTK
GlucoTrack, Inc. (GCTK) P/E ratio
GlucoTrack, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 0.0× (October 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
| FY2015 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Dec 2019 | 0.0× | — |
| Sep 2019 | 0.0× | — |
| Jun 2019 | 0.0× | — |
| Mar 2019 | 0.0× | — |
| 13 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| FEMY Femasys Inc. compare | n/m |
| RVP Retractable Technologies, Inc. compare | n/m |
| LUCY Innovative Eyewear, Inc. compare | n/m |
| NXGL NexGel, Inc. compare | n/m |
| BNGO Bionano Genomics, Inc. compare | n/m |
| GCTK GlucoTrack, Inc. | n/m |
| RGNT Regentis Biomaterials Ltd. compare | — |
| MHUAF Meihua International Medical Technologies Co., Ltd. compare | — |
| CUPR Cuprina Holdings (Cayman) Limited compare | — |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)